Response to flutamide, as second-line therapy after bicalutamide, predicts efficacy of abiraterone, not that of enzalutamide

OBJECTIVE: The objective of this retrospective study was to evaluate whether the effect of second-line therapy of flutamide after bicalutamide can predict the response to abiraterone. RESULTS: Thirty-four patients received abiraterone and 32 received enzalutamide after treatment with second-line flu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Res Notes
Egile Nagusiak: Nakai, Yasushi, Tanaka, Nobumichi, Miyake, Makito, Inoue, Takeshi, Anai, Satoshi, Fujimoto, Kiyohide
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research Note
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5975444/
https://ncbi.nlm.nih.gov/pubmed/29843816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-018-3453-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak